Etranacogene dezaparvovec for treating moderately severe or severe haemophilia B

Supporting evidence

• Evaluation report

• Draft guidance consultation committee papers (PDF 7.12 MB)

  Published:

  24 July 2024

• Final draft guidance committee papers (PDF 2.17 MB)

  Published:

  24 July 2024